🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot phase I trial studies the side effects and how well MUC1 peptide...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2017-12-27
Trial ID
NCT03300817
Treatments Being Tested
The purpose of this study is to determine the effectiveness of a drug calle...
Status
Completed
Location
Hillman Cancer Center
Start Date
2006-06
Trial ID
NCT00374049
Treatments Being Tested
Women with biopsy-proven ductal carcinoma in situ (DCIS) will be enrolled i...
Status
Recruiting
Location
UPMC Magee Womens Hospital
Start Date
2024-02-07
Trial ID
NCT06218303
Treatments Being Tested
All subjects will receive the vaccine subcutaneously every 3 weeks x 3 with...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2012-11
Trial ID
NCT01720836
Treatments Being Tested
The investigators hypothesize that Tadalafil treatment, by lowering Myeloid...
Status
Completed
Location
University of Miami
Start Date
2016-04-25
Trial ID
NCT02544880
The purpose of this study is to evaluate the immune response to MUC1 - poly...
Status
Completed
Location
Digestive Disorders Clinic
Start Date
2008-10
Trial ID
NCT00773097
Treatments Being Tested
This randomized phase II clinical trial studies how well MUC1 peptide-poly-...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2014-06-23
Trial ID
NCT02134925
Treatments Being Tested
RATIONALE: Vaccines made from peptides may help the body build an effectiv...
Status
Completed
Location
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Start Date
2009-08-19
Trial ID
NCT00986609